Telix Pharmaceuticals Limited logo

TLXTelix Pharmaceuticals Limited

TLX Stock Price, Valuation & Chart | Telix Pharmaceuticals Limited

Compare

TLX Historical price chart

TLX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization5.29B
PE Ratio-563.7
EPS-0.03
Trading Volume4.58M
Today's High/Low16.76/15.62
Dividend Yield0.00
52 Week High/Low19.07/8.26
Shares Outstanding338.78M
TLX Financial Statement

TLX Analyst ratings

Buy

Strong buy
6
Buy
8
Hold
0
Sell
0
Strong sell
0

Based on 14 analysts giving stock ratings to TLX in the past 3 months.

TLX Analysis & performance metrics

TLX Company profile

Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation (MTR) products for cancer and rare diseases in Australia, Belgium,…

TLX Management team

Management
Lena Moran-Adams L.L.B.
Group General Counsel
Craig UlrickCTO
Chief Information Officer
Michael Wheatcroft B.Sc., BSc(Hons), Ph.D., Ph.D., (Cantab)
Chief Scientist
Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBACEO
Co-Founder, MD, Group Chief Executive Officer & Executive Director
Andreas Kluge M.D., Ph.D.
Chief Medical Advisor
Darren PattiCOO
Group Chief Operating Officer
Richard Valeix M.B.A.CEO
Chief Executive Officer of Telix Therapeutics
Darren Smith B.Bus., FCPA, M.B.A.CFO
Group Chief Financial Officer
Total 8 executives

TLX Frequently asked questions

What is Telix Pharmaceuticals Limited (TLX) Stock Price?

Current stock price of Telix Pharmaceuticals Limited (TLX) stock is $15.620. The stock price is -10.13% lower in the session. The intraday range can be seen from this page. Volume of Telix Pharmaceuticals Limited (TLX) stock is 4.58M.

Last updated at 21 Aug 2026, 06:10 am.

Why is the Telix Pharmaceuticals Limited (TLX) stock price going up or down today?

The stock price of Telix Pharmaceuticals Limited (TLX) can change with earnings, company news, and overall market sentiment. Telix Pharmaceuticals Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Telix Pharmaceuticals Limited stock expensive at its current price?

Whether Telix Pharmaceuticals Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TLX on this page is -563.70. EPS on this page is -0.03. Compare those figures with peers and growth expectations before deciding if the current Telix Pharmaceuticals Limited price is justified.

How has the stock price of Telix Pharmaceuticals Limited (TLX) performed historically?

Historical performance for Telix Pharmaceuticals Limited (TLX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TLX reacted to past earnings and market events.

Should I buy Telix Pharmaceuticals Limited (TLX) stock, at this price?

Buying Telix Pharmaceuticals Limited (TLX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.